8-K: Enphys Acquisition Corp. Secures Extension and Funding Through Promissory Notes

Enphys Acquisition Corp. extends its business combination deadline to December 8, 2024, and secures up to $600,000 in funding through promissory notes.

Summary

• Enphys Acquisition Corp. has extended its deadline to complete a business combination from June 8, 2024, to December 8, 2024.
• This extension was approved by shareholders at an extraordinary general meeting on June 5, 2024.
• The company issued a Third Extension Note for up to $300,000, with monthly deposits of up to $50,000 into the trust account until the earlier of a business combination or December 8, 2024.
• An Operating Expense Promissory Note was also issued, allowing the company to borrow up to $300,000 for operational costs and due diligence, with a 12% interest rate.
• Shareholders redeemed 2,729,098 public shares for approximately $29,878,341.57, at a price of $10.95 per share.
• After redemptions, the trust account balance is approximately $38,632,359.37.
• Enphys Management Company, LLC deposited $50,000 into the trust account on June 10, 2024, as a loan related to the extension.

Sentiment

Score: 4

Explanation: The document indicates a need for an extension and additional funding, which is not ideal. The significant redemptions also suggest a lack of shareholder confidence. The high interest rate on the operating expense note is also a concern.

Positives

• The extension provides Enphys Acquisition Corp. with additional time to find and complete a business combination.
• The funding secured through the promissory notes provides the company with necessary capital for operations and due diligence.
• Shareholder approval for the extension indicates support for the company's strategy.

Negatives

• The redemption of 2,729,098 public shares resulted in a significant reduction of the trust account balance.
• The Operating Expense Promissory Note carries a 12% interest rate, increasing the company's financial obligations.
• Failure to complete a business combination by December 31, 2024, will result in the termination of the Operating Expense Promissory Note and cancellation of related debt.

Risks

• The company may not be able to find a suitable business combination target by the extended deadline.
• The high interest rate on the Operating Expense Promissory Note could strain the company's finances.
• Further redemptions could further reduce the trust account balance.
• The company's ability to repay the promissory notes is contingent on completing a business combination.

Future Outlook

The company has until December 8, 2024, to complete a business combination. The company will continue to seek a suitable target and utilize the funds from the promissory notes for operations and due diligence.

Industry Context

This announcement is typical for SPACs that are approaching their initial business combination deadline. The extension and additional funding are common strategies to provide more time to find a suitable target. The redemptions are also a common occurrence as shareholders may choose to exit if they are not confident in the company's ability to find a suitable target.

Comparison to Industry Standards

• The redemption rate of approximately 23% (2,729,098 shares out of 11,864,619) is within the typical range for SPACs seeking extensions, although it does indicate some shareholder uncertainty.
• The 12% interest rate on the Operating Expense Promissory Note is relatively high, reflecting the risk associated with lending to a SPAC that has not yet completed a business combination. This is higher than some other SPAC bridge loans which can be in the 8-10% range.
• The extension to December 8, 2024, is a common timeframe for SPACs seeking additional time, with many SPACs extending by 6 months or more.
• The use of promissory notes to fund the extension and operations is a standard practice for SPACs, similar to other SPACs such as those that have used similar structures to extend their timelines.

Corporate Governance

Related Party Transactions

• The Third Extension Note and Operating Expense Promissory Note were issued to Enphys Management Company LLC, a related party.

Stakeholder Impact

• Shareholders who did not redeem their shares are now subject to a later deadline for a potential business combination.
• Shareholders who redeemed their shares received approximately $10.95 per share.
• The company's management has additional time to find a suitable business combination target.
• Creditors are exposed to the risk of non-payment if a business combination is not completed by December 31, 2024.

Next Steps

• The company will continue to seek a suitable business combination target.
• The company will utilize the funds from the promissory notes for operations and due diligence.
• The company will need to complete a business combination by December 8, 2024.

Key Dates

Keywords

business combination, promissory note, extension, redemption, trust account, operating expenses, special purpose acquisition company, SPAC